Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients
Conditions
- Cancer
- Non Small Cell Lung Cancer
Interventions
- RADIATION: PET Imaging
- DRUG: Erlotinib
- DRUG: Bevacizumab
Sponsor
University of Utah